Hernia Mesh Lawsuit Average Payout: 2026 Facts

Quick Answer Box

• What is this case? Thousands of product liability lawsuits allege that defective polypropylene hernia mesh products from manufacturers including C.R. Bard, Ethicon (Johnson & Johnson), and Atrium caused chronic pain, infections, mesh migration, organ perforation, and the need for revision surgery.
• Who qualifies? Patients who received a hernia mesh implant and experienced complications such as mesh erosion, bowel adhesion, chronic pain, infection, fistula, or mesh contraction requiring additional surgery.
• What is it worth? The hernia mesh lawsuit average payout ranges from roughly $50,000 to $1 million or more per claimant, depending on injury severity tier, manufacturer, and whether the case resolved through settlement or jury verdict.

The hernia mesh lawsuit average payout in 2026 varies widely, but confirmed settlement data and jury verdicts place most resolved claims between $50,000 and $1 million per plaintiff. That range depends on the manufacturer, the specific product implanted, the severity of the complication, and whether revision surgery was required.

More than 20,000 hernia mesh lawsuits have been filed in federal MDL proceedings. Thousands more sit in state courts across Georgia, California, and Rhode Island. The pace of settlement negotiations has accelerated since 2023, with Bard/Davol cases moving through a tiered resolution program under MDL 2846 in Ohio.

Readers also liked: AI Lawsuit News 2026: Cases, Claims, Who Qualifies

The litigation is not a single lawsuit. It is a collection of individual claims consolidated for pretrial efficiency. Each plaintiff's payout depends on where their case falls within the settlement matrix, a points-based system that assigns value based on documented medical harm.

What follows is a section-by-section breakdown of payout ranges, manufacturer-specific settlements, tier criteria, eligibility rules, filing deadlines, and the current litigation status as of 2026.

Hernia Mesh Lawsuit Average Payout in 2026

The hernia mesh lawsuit average payout in 2026 falls between $50,000 and $250,000 for the majority of settled claims, with high-severity cases reaching $500,000 to $1.2 million or more. These figures reflect both negotiated settlements and bellwether jury verdicts that have shaped defendant behavior.

Bard/Davol cases in MDL 2846 have produced the most settlement data. The resolution program administered under Judge Sargus's oversight assigns each claim a tier. Payments scale from the lowest tier (minor complications, no revision surgery) to the highest (organ perforation, multiple revision surgeries, permanent disability).

A small percentage of plaintiffs have received amounts exceeding $1.5 million. Those cases typically involve bowel resection, ostomy placement, or chronic pain so severe it results in disability. Cases involving mesh migration into vital organs also trend toward the top of the payout spectrum.

*Attorney Insight: Attorneys handling these claims emphasize that the single largest factor in payout determination is whether the plaintiff required revision surgery and what complications arose from that secondary procedure.*

What Is the Average Payout for Hernia Mesh Lawsuit

The average payout for a hernia mesh lawsuit, when calculated across all resolved claims in MDL 2846 and state court settlements, is estimated at approximately $150,000 to $250,000 per claimant. That figure blends low-tier and high-tier settlements into a single midpoint.

However, using an average is misleading without context. The distribution is not a bell curve. A significant cluster of cases settles in the $60,000 to $120,000 range, representing plaintiffs with documented complications but no revision surgery. A separate cluster at the top includes verdicts and settlements exceeding $500,000.

The question "what is the average payout for hernia mesh lawsuit" is one of the most searched queries in this litigation. The answer depends entirely on three variables:

• Which manufacturer made the mesh (Bard, Ethicon, Atrium, Medtronic)
• What complication occurred (pain, infection, migration, organ damage)
• Whether revision surgery was performed and what resulted from it

*Attorney Insight: Attorneys reviewing these claims note that plaintiffs who underwent documented explant or revision surgery receive materially higher offers than those with conservative treatment records.*

The gap between the lowest settlements and the highest verdicts can be tenfold. A plaintiff with one revision surgery and documented chronic pain may receive $175,000. A plaintiff with bowel resection and permanent colostomy may receive $1 million or more.

Hernia Mesh Lawsuit Settlement Amounts by Tier

Hernia mesh lawsuit settlement amounts are determined by a tiered scoring system, not a flat per-claim payment. Each plaintiff's case is evaluated based on medical records, complication type, treatment history, and the specific mesh product involved.

The Bard/Davol settlement program under MDL 2846 uses a points matrix. Points are assigned for:

• Type of complication (infection scores lower than bowel perforation)
• Number of revision surgeries (each additional surgery adds points)
• Permanent functional impairment (colostomy, chronic pain requiring opioid management)
• Duration of suffering (complications lasting more than 24 months score higher)
• Age at implant (younger plaintiffs with longer life expectancy of impairment may receive more)

The points matrix is not public in its complete form. Lead counsel and defendant representatives negotiate the weighting of each factor. Plaintiffs do not choose their tier. Their medical documentation determines placement.

*Attorney Insight: Attorneys involved in the MDL settlement process stress that incomplete medical records are the most common reason claims receive lower tier placement than the injury would otherwise justify.*

Litigation Watch: Payout amounts in 2026 range from $50,000 to over $1.2 million, driven primarily by revision surgery history and complication severity, with a tiered points matrix controlling individual placement.

Average Settlement for Hernia Mesh Lawsuit Claims

The average settlement for hernia mesh lawsuit claims cannot be stated as a single figure because it shifts based on the manufacturer and the year of resolution. Bard/Davol claims have produced the highest volume of settlement data. Ethicon claims trail behind in resolution pace. Atrium claims are largely resolved at lower average figures.

For Bard/Davol cases resolved through the MDL 2846 program, the working average as of early 2026 tracks near $175,000 to $250,000 per claim. This reflects a mix of Tier 2 and Tier 3 cases that make up the majority of the docket.

For Ethicon hernia mesh cases (distinct from pelvic mesh, which settled years earlier), settlement values have varied more widely. Some early Ethicon Physiomesh cases settled individually in the $100,000 to $400,000 range before a broader program was established.

For Atrium C-QUR cases, most resolved claims fell between $50,000 and $150,000. Atrium's parent company Getinge reached agreements on the majority of its docket by late 2024.

*Attorney Insight: Attorneys tracking settlement data report that Bard cases with documented Ventralex or PerFix Plug products tend to resolve at higher amounts than cases involving generic polypropylene sheets from other manufacturers.*

Current Hernia Mesh Lawsuit Settlements Overview

The current state of hernia mesh lawsuit settlements as of 2026 reflects a litigation that has entered its resolution phase for some manufacturers while remaining active for others. The largest concentration of pending cases sits in MDL 2846 before Judge Sargus in the Southern District of Ohio.

Bard/Davol's parent company, Becton Dickinson (BD), has been the primary settlement driver. BD acquired C.R. Bard in 2017 for $24 billion, inheriting the mesh liability. The company has set aside billions in reserves for mesh litigation, though the exact aggregate settlement fund remains confidential.

Key settlement milestones:

• 2019 to 2021: Early individual Bard settlements in the $100,000 to $500,000 range
• 2022: Bard/Davol initiated a formal settlement program under MDL 2846
• 2023 to 2024: Thousands of Bard claims processed through the tiered matrix
• 2025: Atrium cases largely resolved; Ethicon negotiations accelerated
• 2026: Remaining Bard claims continue processing; new filings still accepted in many states

Jury verdicts have also set benchmarks. A Rhode Island state court awarded $4.8 million to a single plaintiff in a Bard mesh case. A Georgia state court returned a verdict exceeding $1.5 million. These verdicts, while not binding on settlement values, influence defendant willingness to negotiate.

*Attorney Insight: Attorneys on the plaintiffs' steering committee note that bellwether outcomes in state courts have been more consequential for settlement leverage than federal bellwether scheduling in MDL 2846.*

Johnson and Johnson Hernia Mesh Lawsuit Settlements

Johnson and Johnson hernia mesh lawsuit settlements involve claims against its subsidiary Ethicon, Inc., which manufactured and marketed the Physiomesh Flexible Composite Mesh and other surgical mesh products. J&J voluntarily withdrew Physiomesh from the global market in May 2016 after internal studies showed higher-than-expected rates of reoperation and recurrence.

Ethicon hernia mesh cases were initially consolidated under MDL 2327 in the Southern District of West Virginia, though that MDL primarily addressed pelvic mesh. Hernia mesh claims against Ethicon have been filed both within that framework and in separate state court actions.

Settlement details for J&J/Ethicon hernia mesh claims:

• Physiomesh cases have settled individually in the $100,000 to $500,000 range
• Proceed Surgical Mesh claims have generated settlements in the $80,000 to $300,000 range
• J&J has not announced a global settlement fund for hernia mesh comparable to its pelvic mesh resolution, which exceeded $8 billion across all claims

J&J's approach to hernia mesh settlements has differed from Bard's. Rather than establishing a single tiered program, J&J has preferred individual negotiations and mediation. That strategy has left many Ethicon plaintiffs waiting longer for resolution than their Bard counterparts.

*Attorney Insight: Attorneys representing Ethicon plaintiffs report that cases with documented Physiomesh product identification (via operative reports or explant pathology) settle faster and at higher values than cases where mesh manufacturer identification is uncertain.*

Litigation Watch: Bard/Davol leads in settlement volume and program structure, J&J/Ethicon prefers case-by-case mediation, and Atrium cases are mostly concluded, creating a staggered resolution landscape across manufacturers.

Bard Hernia Mesh Lawsuit Settlement Status

Bard hernia mesh lawsuit settlement activity is centered in MDL No. 2846, captioned *In Re: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation*, pending in the U.S. District Court for the Southern District of Ohio before Judge Edmund A. Sargus Jr.

As of 2026, MDL 2846 contains the largest concentration of hernia mesh claims in the federal system. The docket has exceeded 16,000 individual cases at its peak, though thousands have since been resolved through the settlement program or dismissed for insufficient evidence.

The Bard settlement program operates through appointed claims administrators. Key features:

• Tiered payout structure based on a points matrix
• Medical record review by neutral evaluators
• Product identification requirement (plaintiff must prove specific Bard/Davol mesh was implanted)
• Revision surgery documentation as a primary scoring factor
• Lien resolution process for Medicare, Medicaid, and private insurance reimbursement

Becton Dickinson's financial disclosures to the SEC have acknowledged multi-billion-dollar reserves for mesh litigation. The company's 2025 10-K filing referenced ongoing settlement costs, though exact per-claim figures remain protected by confidentiality provisions.

*Attorney Insight: Attorneys negotiating within the Bard program note that claims with clear pathology reports identifying the specific Bard product (Ventralex, PerFix Plug, 3DMax) resolve significantly faster than claims with ambiguous product identification.*

Atrium Hernia Mesh Lawsuit Payout Details

Atrium hernia mesh lawsuit payouts relate to claims against Atrium Medical Corporation, now owned by Getinge AB, primarily involving the C-QUR mesh product. C-QUR was marketed with an Omega-3 fatty acid coating (fish oil derivative) promoted as reducing post-surgical adhesion. Plaintiffs allege the coating triggered inflammatory reactions, chronic pain, and infection.

Atrium mesh litigation has been smaller in scale than Bard or Ethicon proceedings. Most claims were filed in the U.S. District Court for the District of New Hampshire and in various state courts. No formal MDL was created specifically for Atrium hernia mesh, though cases were coordinated informally.

Payout data for Atrium/C-QUR cases:

• Low-severity claims: $30,000 to $75,000
• Moderate claims (infection, one revision): $75,000 to $150,000
• High-severity claims (multiple revisions, chronic inflammatory response): $150,000 to $350,000

Getinge resolved the majority of its C-QUR docket by late 2024, with remaining stragglers settling through 2025. Few new Atrium claims are being filed in 2026, as the statute of limitations has expired for most potential plaintiffs who received C-QUR implants during its peak usage period (2010 to 2016).

*Attorney Insight: Attorneys who handled Atrium claims report that the fish-oil coating created a distinctive injury profile, making causation easier to prove than in standard polypropylene mesh cases, but that the overall settlement values were lower because Getinge's litigation exposure was smaller in scale.*

For a deeper understanding, check Drake UMG Lawsuit 2026: Claims, Court Status, Outcome

Hernia Mesh Settlement Tiers and Scoring Criteria

Hernia mesh settlement tiers are the mechanism by which individual claim value is determined within manufacturer-specific resolution programs. The tier system assigns numerical scores to each plaintiff's case based on documented medical factors, then places the case in a payment bracket.

The scoring criteria used in the Bard/Davol program under MDL 2846 include:

• Complication type and severity
• Chronic pain without other complication: lowest score
• Mesh infection requiring antibiotics: moderate score
• Mesh migration or erosion into adjacent tissue: high score
• Bowel perforation, obstruction, or fistula: highest score

• Surgical history post-implant
• No revision surgery: minimal points
• One revision or explant surgery: significant points
• Multiple revision surgeries: maximum surgical-history points
• Ostomy placement (temporary or permanent): top-tier modifier

• Functional impairment
• Return to normal activity: no impairment points
• Permanent activity restrictions: moderate points
• Total disability or inability to work: maximum impairment points

• Duration and documentation quality
• Complications documented within 1 year of implant: standard
• Complications persisting beyond 3 years: duration bonus
• Complete medical records including operative reports, pathology, imaging: full credit
• Missing records or gaps in treatment history: point deductions

*Attorney Insight: Attorneys emphasize that tier placement disputes are common and that the appeals process within the settlement program can shift a case from Tier 2 to Tier 3, sometimes adding $100,000 or more to the offer.*

Litigation Watch: The tiered scoring system is the central mechanism controlling individual payouts. Product identification, revision surgery documentation, and complete medical records are the three factors that most frequently determine whether a claim falls in the $75,000 range or the $500,000+ range.

Hernia Mesh Lawsuit Payout Per Person

The hernia mesh lawsuit payout per person is not a fixed amount. Each plaintiff receives an individual offer based on their tier placement, and that offer is subject to deductions before the plaintiff receives a check.

Standard deductions from a gross settlement include:

• Attorney fees: typically 33% to 40% of the gross recovery
• Case expenses: medical record retrieval, expert witness fees, filing costs (usually $2,000 to $15,000)
• Medical lien reimbursement: Medicare, Medicaid, or private insurer reimbursement for treatment related to mesh complications
• Medicare Set-Aside (MSA): if the plaintiff is on Medicare, a portion may be reserved for future related medical expenses

A plaintiff whose case settles at a gross value of $200,000 may receive a net payout of approximately $110,000 to $130,000 after attorney fees, case costs, and lien resolution.

The net payout per person is what actually reaches the plaintiff's account. Gross figures reported in headlines do not reflect reality for individual claimants.

*Attorney Insight: Attorneys handling mass tort cases note that lien resolution often takes 3 to 6 months after settlement agreement, and that the final net amount is not known until all third-party claims are resolved.*

Who Qualifies for Hernia Mesh Lawsuit in 2026

A person qualifies for a hernia mesh lawsuit in 2026 if they received a hernia mesh implant and subsequently experienced a qualifying medical complication that they attribute to a defect in the mesh product. The claim must fall within the applicable statute of limitations.

Qualifying complications include:

• Chronic pain at the mesh site persisting beyond normal post-surgical recovery
• Mesh infection (bacterial colonization of the mesh material)
• Mesh migration (movement of the mesh from its original placement)
• Mesh erosion or shrinkage (contraction of polypropylene material)
• Bowel adhesion, obstruction, or perforation
• Fistula formation
• Hernia recurrence at or near the mesh site
• Seroma (fluid collection) requiring drainage or revision

Eligibility requirements:

• Product identification: Plaintiff must demonstrate which manufacturer's mesh was implanted. Operative reports, hospital billing records, and explant pathology can establish this.
• Medical documentation: Treatment records must connect the complication to the mesh, not to an unrelated surgical issue.
• Statute of limitations: The filing must be timely under the plaintiff's state law (see state-by-state section below).

Patients who received mesh implants for inguinal, ventral, incisional, or umbilical hernia repair may all qualify. The type of hernia is less important than the product used and the complication experienced.

*Attorney Insight: Attorneys screening these cases report that approximately 30% to 40% of inquiries are disqualified because the potential plaintiff cannot identify the manufacturer of their mesh, highlighting the importance of obtaining surgical records early.*

Hernia Mesh Revision Surgery Lawsuit Claims

Hernia mesh revision surgery lawsuit claims are among the highest-value cases in this litigation. Plaintiffs who required one or more revision or explant surgeries to remove or replace defective mesh receive substantially higher settlement offers than those treated conservatively.

Revision surgery adds value for three reasons:

1. Objective proof of product failure. If a surgeon removed the mesh because it migrated, eroded, or became infected, the operative report documents the defect in clinical terms.
2. Additional medical costs. Revision surgery generates quantifiable economic damages: hospital bills, anesthesia, surgeon fees, post-operative care, rehabilitation.
3. Pain and suffering amplification. Undergoing a second (or third) abdominal surgery carries documented risks of adhesion, nerve damage, and prolonged recovery.

Claims involving revision surgery break down as follows:

Approximately 60% to 70% of plaintiffs in MDL 2846 allege at least one revision surgery. This makes revision the single most common basis for elevated tier placement.

*Attorney Insight: Attorneys point out that the pathology report from a mesh explant procedure is often the most powerful piece of evidence in the case, as it can demonstrate mesh degradation, inflammatory tissue response, and bacterial contamination visible under microscopy.*

Litigation Watch: Revision surgery documentation is the primary driver of high-value settlements, with explant pathology reports serving as the single most important evidentiary document in tier placement disputes. Plaintiffs without revision surgery history can still qualify but should expect lower offers.

Hernia Mesh Lawsuit Filing Deadline for 2026

The hernia mesh lawsuit filing deadline depends on the state where the plaintiff resides or where the implant surgery occurred. There is no single federal deadline. Each state's statute of limitations governs when a claim must be filed.

Most hernia mesh claims fall under product liability or personal injury statutes of limitations. These range from 1 year to 6 years depending on the state. Many states apply a discovery rule, meaning the clock starts when the plaintiff knew or should have known that the mesh caused their complication, not when the mesh was implanted.

Critical deadline considerations for 2026:

• Plaintiffs who discovered complications in 2024 and live in a state with a 2-year statute must file by 2026 or risk losing their claim permanently
• Some states toll (pause) the statute of limitations for minors, incapacitated persons, or during periods of fraudulent concealment by the manufacturer
• Filing in the MDL does not change the applicable state deadline. The plaintiff's state law still governs timeliness.

Missed deadlines cannot be fixed after the fact. Unlike some other aspects of litigation that can be negotiated, the statute of limitations is a hard cutoff enforced by courts.

*Attorney Insight: Attorneys screening new cases in 2026 report that statute of limitations issues are now the most common reason for case rejection, particularly for patients who experienced complications years ago but delayed seeking legal counsel.*

Hernia Mesh Lawsuit Statute of Limitations by State

The hernia mesh lawsuit statute of limitations by state determines whether a claim filed in 2026 is timely. The following table reflects the general personal injury or product liability limitation period in each state. The discovery rule may extend these periods depending on when the plaintiff became aware of the mesh-related injury.

This is not an exhaustive list. Every U.S. state and territory has its own limitation period. Some states also impose a statute of repose, which sets an absolute outer deadline (often 10 to 12 years from the date of implant) regardless of when the injury was discovered.

*Attorney Insight: Attorneys handling multi-state filings note that Kentucky, Louisiana, and Tennessee's one-year windows create the most urgent filing pressure and that plaintiffs in those states who delay consultation by even a few months may lose their claims entirely.*

Hernia Mesh MDL Status in 2026

The hernia mesh MDL status in 2026 reflects a litigation that has moved past its discovery and bellwether phases and into active settlement processing. MDL No. 2846 remains the central federal proceeding for Bard/Davol claims.

Key MDL 2846 developments through 2026:

• Bellwether selection and preparation: Several cases were prepared for trial in 2022 to 2024 to test legal theories and establish settlement benchmarks
• Settlement program launch: Bard/Davol established a formal resolution program with plaintiffs' leadership, processing claims through the tiered matrix
• Lone Pine orders: Judge Sargus issued Case Management Orders requiring plaintiffs to produce threshold evidence (medical records, product identification, expert certification) or face dismissal
• Dismissals: Thousands of cases that failed Lone Pine requirements have been dismissed, narrowing the active docket
• Remaining cases: Several thousand active claims continue processing through the settlement program

For Ethicon hernia mesh claims, the federal litigation picture is less centralized. Some cases remain in MDL 2327 in West Virginia. Others have been filed in state courts in New Jersey, California, and Texas. J&J has not established a global resolution program comparable to Bard's.

*Attorney Insight: Attorneys involved in MDL 2846 report that the Lone Pine orders have been effective in clearing weak claims from the docket, which has improved settlement offer amounts for remaining plaintiffs with strong documentation.*

Litigation Watch: MDL 2846 is in its resolution phase with an active settlement program. Ethicon hernia mesh cases lack a comparable centralized program. Plaintiffs in either track should verify their case status and deadline compliance as the litigation narrows.

Along the same lines: Shein Lawsuit 2026: Claims, Status and Who Qualifies

Hernia Mesh Lawsuit 2026 Update

The hernia mesh lawsuit 2026 update shows a litigation at a turning point. The peak of new filings has passed. Settlement processing for Bard/Davol is ongoing. Ethicon resolution efforts are accelerating but remain less structured. Atrium's docket is essentially closed.

Major developments in 2025 and early 2026:

• Becton Dickinson continued increasing litigation reserves, with SEC filings reflecting billions in accrued mesh-related liabilities
• Bard settlement program expanded to cover additional product lines beyond Ventralex and PerFix Plug
• Ethicon/J&J began structured mediation sessions for select Physiomesh cases, signaling movement toward broader resolution
• FDA continued receiving adverse event reports related to polypropylene hernia mesh through the MAUDE database, with over 100,000 cumulative reports across all mesh types since tracking began
• State court activity remained strong in Georgia, Rhode Island, California, and New Jersey, where plaintiffs pursued individual trials rather than waiting for MDL resolution

Upcoming 2026 expectations:

• Additional Bard settlement offers to Tier 1 and Tier 2 claimants
• Possible Ethicon global settlement announcement
• Continued statute of limitations expirations in short-window states
• Potential for additional bellwether trials in state courts if settlement negotiations stall

*Attorney Insight: Attorneys following the 2026 docket report that the window for new filings is narrowing rapidly and that plaintiffs who have not yet filed should treat 2026 as an urgent action year rather than a wait-and-see period.*

How Long Do Hernia Mesh Lawsuits Take

Hernia mesh lawsuits take 2 to 5 years from initial filing to settlement payment for most plaintiffs. Cases that go to trial can take longer. Cases enrolled in an active settlement program may resolve in 12 to 24 months from enrollment.

The timeline depends on several factors:

• Filing location: MDL cases follow the court's scheduling orders. State court cases follow local court calendars.
• Settlement program enrollment: Plaintiffs in the Bard/Davol program may receive offers within 12 to 18 months of submitting complete documentation.
• Medical record completeness: Cases with gaps in records face delays during the review process.
• Lien resolution: After a settlement is agreed upon, Medicare and insurance lien negotiation can add 3 to 6 months before the plaintiff receives payment.
• Appeals or disputes: If a plaintiff disputes their tier placement, the internal appeals process adds time.

Plaintiffs who filed in 2020 or 2021 and enrolled in the Bard settlement program have largely received or are close to receiving final payments. Plaintiffs filing for the first time in 2026 should expect a total timeline of 2 to 3 years to resolution, assuming no trial.

*Attorney Insight: Attorneys managing case timelines note that the fastest path to payment is through complete medical record submission at the outset, as incomplete records trigger rounds of supplemental requests that can delay the process by a year or more.*

Frequently Asked Questions

What is the average payout for a hernia mesh lawsuit in 2026?

The average payout in 2026 ranges from approximately $150,000 to $250,000 per claimant across all manufacturers and tier levels.

High-severity cases involving organ damage or permanent disability have settled for $500,000 to $1.2 million or more.

Low-severity cases without revision surgery typically settle in the $50,000 to $100,000 range.

How do I know if I qualify for a hernia mesh lawsuit?

You may qualify if you received a hernia mesh implant and experienced complications such as chronic pain, infection, mesh migration, bowel obstruction, or the need for revision surgery.

Your claim must fall within your state's statute of limitations, and you must be able to identify the manufacturer of your mesh.

Operative reports and hospital records are the primary documents used to establish eligibility.

What is the deadline to file a hernia mesh lawsuit?

The deadline is determined by your state's statute of limitations, which ranges from 1 to 6 years from the date you discovered or should have discovered the mesh-related injury.

There is no single federal deadline.

Plaintiffs in states with one-year windows (Kentucky, Louisiana, Tennessee) face the most urgent filing pressure in 2026.

Which hernia mesh manufacturers have paid settlements?

C.R. Bard (Davol Inc.), now owned by Becton Dickinson, has paid the most settlements through the MDL 2846 program.

Ethicon (Johnson & Johnson) has settled select Physiomesh and Proceed Mesh cases on a case-by-case basis.

Atrium Medical (Getinge) has resolved the majority of its C-QUR mesh docket through 2024 and 2025 settlements.

How long does a hernia mesh lawsuit take from filing to payout?

Most hernia mesh lawsuits take 2 to 4 years from filing to final payment.

Cases enrolled in an active settlement program like Bard's MDL 2846 program may resolve in 12 to 24 months from enrollment.

Lien resolution with Medicare or private insurers can add 3 to 6 months after settlement agreement.

Does having revision surgery increase my hernia mesh settlement amount?

Yes. Revision surgery is the single most significant factor in increasing settlement value.

Plaintiffs who underwent mesh explant or revision surgery typically receive offers 2 to 5 times higher than those treated without surgery.

Multiple revision surgeries, bowel resection, or ostomy placement push cases into the highest settlement tiers.

The hernia mesh litigation in 2026 is no longer in its early stages. Settlement programs are running. Filing windows are closing. Payout amounts are being determined right now based on medical records that either exist in complete form or do not.

Plaintiffs who have experienced mesh complications and have not yet filed should verify their state's statute of limitations and locate their surgical records. Consulting with a product liability or mass tort attorney who is actively handling hernia mesh claims is the step that separates informed waiting from missed opportunity.

The difference between a Tier 1 and a Tier 3 settlement can be hundreds of thousands of dollars. That difference often comes down to documentation, not injury severity alone.

On a related note, check out Select Home Warranty Lawsuit 2026: Full Case Guide